ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Ordinary Shares, nominal value Euro 0.04 per share
Shares outstanding
105,371,575
Total 13F shares
45,445,352
Share change
+851,497
Total reported value
$364,779,631
Put/Call ratio
142%
Price per share
$8.01
Number of holders
72
Value change
+$6,635,516
Number of buys
37
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP N71542109?
CUSIP N71542109 identifies PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q4 2021

As of 31 Dec 2021, ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,445,352 shares. The largest 10 holders included RTW INVESTMENTS, LP, Privium Fund Management B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, GOLDMAN SACHS GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, COWEN AND COMPANY, LLC, and Opaleye Management Inc.. This page lists 72 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.